The Business Times
PERSPECTIVE
·
SUBSCRIBERS

After a Covid-fuelled adrenaline rush, biotech is crashing

Many firms will not survive

Published Fri, Aug 12, 2022 · 04:48 PM

THREE years ago, no one had heard of BioNTech. Today, the German biotechnology firm enjoys global renown, as well as annual revenues of US$19 billion.

The company owes both the lustre and the lucre chiefly to the successful mRNA Covid-19 vaccine which it d…

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

KEYWORDS IN THIS ARTICLE

READ MORE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Columns

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here